España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Compass Pathways
CMPS
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$7.15
0.03
0.42%
Pre-Market: 6:15 PM EDT
15 minutes delayed
Get Report
Watch
Compass Pathways (CMPS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Compass Pathways (NASDAQ:CMPS) Stock
Compass Pathways Stock (NASDAQ: CMPS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 21, 2024
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Wednesday, June 12, 2024
'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk
Wednesday, June 05, 2024
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
What's Going On With MindMed And Psychedelic Stocks?
Erica Kollmann
Shares of psychedelics companies are trading ...
Benzinga Newsdesk
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, June 03, 2024
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Friday, May 24, 2024
'Top Federal Drug Official Says There's 'Trem...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on Compass...
Benzinga Newsdesk
Thursday, May 09, 2024
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
Nina Zdinjak
Wednesday, May 08, 2024
Compass Pathways Reports Q1 Cash And Cash Equ...
Benzinga Newsdesk
Compass Pathways Q1 2024 GAAP EPS $(0.55) Mis...
Benzinga Newsdesk
Compass Pathways Announced Topline Results Fr...
Benzinga Newsdesk
Tuesday, May 07, 2024
"FDA Expert Committee Will Review MDMA-Assist...
Benzinga Newsdesk
Thursday, May 02, 2024
Compass Pathways, Mindful Health Solutions En...
Benzinga Newsdesk
Tuesday, April 30, 2024
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Monday, April 29, 2024
Compass Pathways And Journey Clinical Have Co...
Benzinga Newsdesk
Friday, April 19, 2024
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
Caleb Naysmith
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Thursday, April 18, 2024
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Tuesday, April 16, 2024
Who's Who In Cannabis: Latest Executive Changes You Should Know About
Jelena Martinovic
Monday, April 01, 2024
COMPASS Pathways shares are trading higher af...
Benzinga Newsdesk
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Morgan Stanley Initiates Coverage On Compass ...
Benzinga Newsdesk
Saturday, March 30, 2024
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Lara Goldstein
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Lara Goldstein
Thursday, March 28, 2024
Compass Pathways Board Chair And Co-Founder G...
Benzinga Newsdesk
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Wednesday, March 13, 2024
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Lara Goldstein
Thursday, March 07, 2024
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Lara Goldstein
Wednesday, March 06, 2024
Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
Lara Goldstein
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Compass...
Benzinga Newsdesk
Thursday, February 29, 2024
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment
Lara Goldstein
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
Lara Goldstein
Compass Pathways Says Cash Position Of $220.2...
Benzinga Newsdesk
Compass Pathways Q4 EPS $(0.53) Misses $(0.33...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Earnings Preview For Compass Pathways
Benzinga Insights
Thursday, February 15, 2024
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Monday, February 12, 2024
'FDA Grants Priority Review Of MDMA-Assisted ...
Benzinga Newsdesk
Friday, February 02, 2024
Psilocybin Mushrooms For Sale: Is It Legal Anywhere In America?
Lara Goldstein
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Friday, January 26, 2024
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch